Home » Topics » Regulatory » Patents

Patents
RSS

Mallinckrodt describes diagnostic agents for serotonin-related disorders

Nov. 19, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Antineoplastic PTP inhibitors disclosed by Department of Health & Human Services

Nov. 19, 1996

RCT reports novel circular oligonucleotides

Nov. 19, 1996

New anti-HIV agents discovered by Hoechst

Nov. 19, 1996

NO donors reported for cancer chemotherapy

Nov. 19, 1996

Astra claims orally active peptide immunomodulators

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.